IMAC Holdings Financials
BACK Stock | USD 1.04 0.03 2.80% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 0.57 | 0.6032 |
|
|
Investors should never underestimate IMAC Holdings' ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor IMAC Holdings' cash flow, debt, and profitability to make informed and accurate decisions about investing in IMAC Holdings.
Net Income |
|
IMAC | Select Account or Indicator |
Understanding current and past IMAC Holdings Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of IMAC Holdings' financial statements are interrelated, with each one affecting the others. For example, an increase in IMAC Holdings' assets may result in an increase in income on the income statement.
IMAC Holdings Stock Summary
IMAC Holdings competes with Oncology Institute, Aveanna Healthcare, P3 Health, HCA Holdings, and Airsculpt Technologies. IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee. Imac Holdings operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 154 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
CUSIP | 44967K104 44967K302 |
Location | Tennessee; U.S.A |
Business Address | 1605 Westgate Circle, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.imacholdings.com |
Phone | 844 266 4622 |
Currency | USD - US Dollar |
IMAC Holdings Key Financial Ratios
Return On Equity | -3.32 | ||||
Price To Sales | 0.59 X | ||||
Revenue | 5.2 M | ||||
Gross Profit | 18.34 K | ||||
EBITDA | (5.95 M) |
IMAC Holdings Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.4M | 19.7M | 27.2M | 11.1M | 1.1M | 1.1M | |
Other Current Liab | 421.0K | 339.4K | 337.9K | 5.6M | 1.3M | 2.1M | |
Net Debt | 8.0M | 6.5M | (1.2M) | 3.4M | (221.5K) | (210.4K) | |
Retained Earnings | (10.0M) | (15.0M) | (28.2M) | (46.5M) | (55.9M) | (53.1M) | |
Accounts Payable | 2.9M | 1.7M | 2.5M | 568.6K | 584.1K | 554.9K | |
Cash | 373.7K | 2.6M | 7.1M | 763.2K | 221.5K | 210.4K | |
Net Receivables | 1.3M | 1.5M | 1.2M | 2.9M | 731.1K | 1.3M | |
Other Current Assets | 633.3K | 619.7K | 739.2K | 10.1M | 191.5K | 182.0K | |
Total Liab | 12.5M | 11.9M | 9.3M | 6.4M | 1.9M | 1.8M | |
Total Current Assets | 2.6M | 4.8M | 9.1M | 4.2M | 1.1M | 1.1M | |
Common Stock | 8.9K | 12.8K | 26.2K | 32.9K | 1.1K | 1.1K | |
Other Assets | 1.2M | 987.1K | 674.6K | (762K) | (685.8K) | (651.5K) | |
Short Term Debt | 2.5M | 3.6M | 1.8M | 1.4M | 1.3M | 1.9M | |
Long Term Debt | 2.1M | 2.0M | 104.7K | 53.0K | 47.7K | 45.3K | |
Net Invested Capital | 13.6M | 14.9M | 18.3M | 4.8M | (752.7K) | (715.0K) | |
Short Long Term Debt | 1.5M | 2.5M | 254.5K | 51.7K | 46.5K | 44.2K | |
Capital Stock | 8.9K | 12.8K | 26.2K | 32.9K | 1.2K | 1.1K | |
Net Working Capital | (3.5M) | (1.2M) | 4.1M | 494.1K | (752.6K) | (790.3K) | |
Intangible Assets | 7.2M | 6.6M | 5.8M | 1.4M | 1.2M | 1.2M |
IMAC Holdings Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 897.7K | 563.1K | 504.1K | 14.2K | 99.0K | 94.1K | |
Total Revenue | 15.1M | 12.8M | 14.4M | 16.2M | 5.2M | 9.8M | |
Gross Profit | 12.6M | 11.2M | 12.8M | 14.7M | 3.8M | 3.7M | |
Operating Income | (6.2M) | (6.5M) | (9.9M) | (9.8M) | (6.4M) | (6.7M) | |
Ebit | (6.2M) | (5.0M) | (10.0M) | (11.8M) | (6.4M) | (6.7M) | |
Ebitda | (4.6M) | (3.3M) | (8.4M) | (10.2M) | (5.9M) | (6.2M) | |
Cost Of Revenue | 2.5M | 1.6M | 1.6M | 1.5M | 1.3M | 1.3M | |
Income Before Tax | (7.0M) | (5.5M) | (10.5M) | (18.3M) | (6.5M) | (6.8M) | |
Net Income | (7.4M) | (5.6M) | (11.1M) | (26.7M) | (9.4K) | (9.9K) | |
Income Tax Expense | 427.2K | 24.4K | 561.4K | 8.4M | 1.7M | 1.4M | |
Net Interest Income | (889.9K) | (557.0K) | (501.2K) | (3.6K) | (65.5K) | (68.8K) | |
Interest Income | 7.8K | 6.1K | 2.9K | 10.6K | 33.5K | 35.2K |
IMAC Holdings Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 179.4K | 2.3M | 4.5M | (6.4M) | (541.7K) | (514.6K) | |
Free Cash Flow | (5.3M) | (6.4M) | (8.4M) | (10.6M) | (2.8M) | (2.9M) | |
Other Non Cash Items | 639.2K | 237.1K | 255.8K | 8.4M | 5.3M | 5.6M | |
Capital Expenditures | 1.2M | 369.7K | 763.4K | 331.4K | 1.0 | 0.95 | |
Net Income | (7.0M) | (5.5M) | (10.5M) | (18.3M) | (9.4M) | (9.9M) | |
End Period Cash Flow | 373.7K | 2.6M | 7.1M | 763.2K | 221.5K | 210.4K | |
Depreciation | 1.6M | 1.7M | 1.6M | 1.6M | 403.6K | 383.4K | |
Investments | (1.1M) | (569.7K) | (2.5M) | (260.0K) | (1.9M) | (2.0M) |
IMAC Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining IMAC Holdings's current stock value. Our valuation model uses many indicators to compare IMAC Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across IMAC Holdings competition to find correlations between indicators driving IMAC Holdings's intrinsic value. More Info.IMAC Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, IMAC Holdings' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value IMAC Holdings by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.IMAC Holdings Systematic Risk
IMAC Holdings' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. IMAC Holdings volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on IMAC Holdings correlated with the market. If Beta is less than 0 IMAC Holdings generally moves in the opposite direction as compared to the market. If IMAC Holdings Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one IMAC Holdings is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of IMAC Holdings is generally in the same direction as the market. If Beta > 1 IMAC Holdings moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in IMAC Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various IMAC Holdings' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of IMAC Holdings growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
IMAC Holdings November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of IMAC Holdings help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of IMAC Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of IMAC Holdings based on widely used predictive technical indicators. In general, we focus on analyzing IMAC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build IMAC Holdings's daily price indicators and compare them against related drivers.
Information Ratio | (0.15) | |||
Maximum Drawdown | 23.76 | |||
Value At Risk | (7.91) | |||
Potential Upside | 7.32 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in IMAC Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy IMAC Stock please use our How to buy in IMAC Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IMAC Holdings. If investors know IMAC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IMAC Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.03) | Revenue Per Share 7.719 | Quarterly Revenue Growth (0.59) | Return On Assets (0.38) | Return On Equity (3.32) |
The market value of IMAC Holdings is measured differently than its book value, which is the value of IMAC that is recorded on the company's balance sheet. Investors also form their own opinion of IMAC Holdings' value that differs from its market value or its book value, called intrinsic value, which is IMAC Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IMAC Holdings' market value can be influenced by many factors that don't directly affect IMAC Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IMAC Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if IMAC Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IMAC Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.